{"groups":[{"description":"Pomalidomide: 2 mg orally once daily, days 1-28 of 28 day cycle\n\nDexamethasone: 40 mg on days 1, 8, 15 ad 22 of 28 day cycle","id":"FG000","title":"Relapsed Myeloma (<4 Prior Regimens): Low Dose"},{"description":"Pomalidomide: 2 mg orally once daily, days 1-28 of 28 day cycle\n\nDexamethasone: 40 mg on days 1, 8, 15 ad 22 of 28 day cycle","id":"FG001","title":"Lenalidomide Refractory Myeloma: Low Dose"},{"description":"Pomalidomide: 2 mg orally once daily, days 1-28 of 28 day cycle\n\nDexamethasone: 40 mg on days 1, 8, 15 ad 22 of 28 day cycle","id":"FG002","title":"Bortezomib/Lenalidomide Refractory/Relapsed Myeloma: Low Dose"},{"description":"Pomalidomide: 4 mg orally once daily, days 1-28 of 28 day cycle\n\nDexamethasone: 40 mg on days 1, 8, 15 ad 22 of 28 day cycle","id":"FG003","title":"Bortezomib/Lenalidomide Relapsed/Refractory Myeloma: High Dose"},{"description":"Pomalidomide: 4 mg orally once daily, days 1-28 of 28 day cycle\n\nDexamethasone: 40 mg on days 1, 8, 15 ad 22 of 28 day cycle","id":"FG004","title":"Relapsed Myeloma (< 4 Prior Regimens): High Dose"},{"description":"Pomalidomide: 4 mg orally once daily, days 1-21 of 28 day cycle\n\nDexamethasone: 40 mg on days 1, 8, 15 ad 22 of 28 day cycle","id":"FG005","title":"Relapsed/Refractory Myeloma: High Dose"},{"description":"Pomalidomide: 2 mg orally once daily, days 1-28 of 28 day cycle\n\nDexamethasone: 40 mg on days 1, 8, 15 ad 22 of 28 day cycle","id":"FG006","title":"Relapsed Amyloidosis: Low Dose"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"3"},{"groupId":"FG004","numSubjects":"4"},{"groupId":"FG005","numSubjects":"10"},{"groupId":"FG006","numSubjects":"3"}],"type":"Adverse Event"},{"reasons":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"2"},{"groupId":"FG003","numSubjects":"3"},{"groupId":"FG004","numSubjects":"2"},{"groupId":"FG005","numSubjects":"2"},{"groupId":"FG006","numSubjects":"6"}],"type":"Death"},{"reasons":[{"groupId":"FG000","numSubjects":"2"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"1"},{"groupId":"FG004","numSubjects":"1"},{"groupId":"FG005","numSubjects":"5"},{"groupId":"FG006","numSubjects":"5"}],"type":"Withdrawal by Subject"},{"reasons":[{"groupId":"FG000","numSubjects":"2"},{"groupId":"FG001","numSubjects":"2"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"2"},{"groupId":"FG004","numSubjects":"6"},{"groupId":"FG005","numSubjects":"7"},{"groupId":"FG006","numSubjects":"1"}],"type":"Alternative Treatment"},{"reasons":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"2"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"2"},{"groupId":"FG004","numSubjects":"1"},{"groupId":"FG005","numSubjects":"3"},{"groupId":"FG006","numSubjects":"3"}],"type":"Physician discretion"},{"reasons":[{"groupId":"FG000","numSubjects":"10"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"1"},{"groupId":"FG004","numSubjects":"9"},{"groupId":"FG005","numSubjects":"25"},{"groupId":"FG006","numSubjects":"6"}],"type":"Continues on treatment"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"60"},{"groupId":"FG001","numSubjects":"34"},{"groupId":"FG002","numSubjects":"35"},{"groupId":"FG003","numSubjects":"35"},{"groupId":"FG004","numSubjects":"60"},{"groupId":"FG005","numSubjects":"120"},{"groupId":"FG006","numSubjects":"33"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"39"},{"groupId":"FG001","numSubjects":"27"},{"groupId":"FG002","numSubjects":"30"},{"groupId":"FG003","numSubjects":"23"},{"groupId":"FG004","numSubjects":"37"},{"groupId":"FG005","numSubjects":"68"},{"groupId":"FG006","numSubjects":"9"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"21"},{"groupId":"FG001","numSubjects":"7"},{"groupId":"FG002","numSubjects":"5"},{"groupId":"FG003","numSubjects":"12"},{"groupId":"FG004","numSubjects":"23"},{"groupId":"FG005","numSubjects":"52"},{"groupId":"FG006","numSubjects":"24"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"preAssignmentDetails":"One patient was deemed ineligible and excluded from all analyses.","recruitmentDetails":"Between November 2007 and March 2012, 7 sequential phase 2 trials (reported as separate arms) were conducted. A total of 378 participants were recruited at Mayo Clinic (Arizona, Florida or Arizona)."}